Olarte, Irma <br/><br/>
MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma.  [electronic resource] 

 -  Hematology (Amsterdam, Netherlands)  Nov 2011 
 - 368-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1607-8454 
<br/><br/><label>Standard No.: </label>10.1179/102453311X13085644680384  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antigens, Neoplasm--genetics<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Blotting, Western<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>L-Lactate Dehydrogenase--blood<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Proteins--genetics<br/>Neoplasm Staging<br/>Prognosis<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Survival Analysis<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult